ROCEPHIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rocephin, and when can generic versions of Rocephin launch?
Rocephin is a drug marketed by Hoffmann La Roche and Roche and is included in five NDAs.
The generic ingredient in ROCEPHIN is ceftriaxone sodium; lidocaine. There are twenty-six drug master file entries for this compound. Additional details are available on the ceftriaxone sodium; lidocaine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ROCEPHIN?
- What are the global sales for ROCEPHIN?
- What is Average Wholesale Price for ROCEPHIN?
Summary for ROCEPHIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 45 |
| Clinical Trials: | 20 |
| Patent Applications: | 4,871 |
| DailyMed Link: | ROCEPHIN at DailyMed |
Recent Clinical Trials for ROCEPHIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ng Teng Fong General Hospital | Phase 3 |
| John Hunter Hospital | Phase 3 |
| Singapore General Hospital | Phase 3 |
US Patents and Regulatory Information for ROCEPHIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hoffmann La Roche | ROCEPHIN | ceftriaxone sodium | INJECTABLE;INJECTION | 062654-002 | Apr 30, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hoffmann La Roche | ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER | ceftriaxone sodium | INJECTABLE;INJECTION | 050624-002 | Feb 11, 1987 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hoffmann La Roche | ROCEPHIN | ceftriaxone sodium | INJECTABLE;INJECTION | 063239-002 | Aug 13, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
